A broad scope — laboratory, clinical and computational
The Vaccine and Infectious Disease Division (VIDD) was established as an institute in 2007 to facilitate and enhance the Hutch’s efforts in infectious disease prevention and vaccine development. The institute achieved division status in 2010 and currently has more than 50 faculty members. Collectively, VIDD integrates the latest in basic, computational and clinical research methods to advance the understanding of infectious disease processes.
The environment of VIDD encourages creativity and innovation through the collaboration of diverse fields, and provides a unique and invaluable opportunity to utilize patient specimen repositories and data in biomedical research. Thus, the translational and multidisciplinary nature of VIDD is a true example of ‘bench to bedside’ science.
VIDD labs utilize microbiology, biochemistry, and molecular and cellular biology methods to investigate the fundamental mechanisms underlying the pathobiology of infectious diseases. The goals of this basic science approach are to learn the key concepts of how the immune system works, how pathogens cause disease and to find ways of alleviating disease burden through preventive, diagnostic and therapeutic modalities including vaccine and drug development.
Computational biologists and biostatisticians accelerate our understanding of infectious diseases and public health via computational, statistical and mathematical modeling methods. We are home to the HIV Vaccine Trials Network (HVTN), the world’s largest clinical trials network for the development and testing of an HIV vaccine, and the Statistical Center for HIV/AIDS Research & Prevention (SCHARP).
A crucial and distinctive component of VIDD is the use of clinical research to reduce human infectious disease burden. Our faculty tackle this goal from many avenues: treatment, prevention, intervention and diagnostics. Many VIDD faculty also hold joint appointments with UW Medicine and SCCA and are involved in a number of clinical trials aimed at finding efficacious treatments and prevention strategies for diseases.
VIDD research spans the globe, with laboratory, clinical and field sites in the Americas, Africa, Asia and Europe. The division has specific initiatives in Uganda, China and the Republic of South Africa to advance the understanding of infection-related cancers and infectious diseases that affect high-risk populations in these regions.
Our scientists around the world include clinicians, clinical trials specialists, statisticians, computational biologists and basic scientists taking pride in their collaborative efforts to predict, detect, treat and prevent infectious diseases in humans.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.